Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)

MLA

Barnaby Edward Young, et al. Design and Implementation of an International, Multi-Arm, Multi-Stage Platform Master Protocol for Trials of Novel SARS-CoV-2 Antiviral Agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Jan. 2022. EBSCOhost, https://doi.org/10.1177/17407745211049829.

APA

Barnaby Edward Young, Shweta Sharma, B. Taylor Thompson, Virginia L. Kan, Christina E. Barkauskas, Abdel Babiker, Andrew N. Phillips, Thomas A. Murray, Roger Paredes, Mahesh K. B. Parmar, Cavan S. Reilly, Elizabeth S. Higgs, Uriel Sandkovsky, Christina C. Chang, Annetine C. Gelijns, H. Clifford Lane, Jason V. Baker, Sarah Pett, Mark N. Polizzotto, … Marc Teitelbaum. (2022). Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). https://doi.org/10.1177/17407745211049829

Chicago

Barnaby Edward Young, Shweta Sharma, B. Taylor Thompson, Virginia L. Kan, Christina E. Barkauskas, Abdel Babiker, Andrew N. Phillips, et al. 2022. “Design and Implementation of an International, Multi-Arm, Multi-Stage Platform Master Protocol for Trials of Novel SARS-CoV-2 Antiviral Agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3),” January. doi:10.1177/17407745211049829.